A short treatment study of aripiprazole in pediatric patients with schizophrenia
Phase 3
- Conditions
- Schizophrenia
- Registration Number
- JPRN-jRCT2080221112
- Lead Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 99
Inclusion Criteria
1) Patients with a diagnosis of schizophrenia according to DSM-IV-TR
2) Male and female patients aged 13-17 years
3) Inpatient or outpatient status
Exclusion Criteria
1) Patients who have a diagnosis of any other disease except schizophrenia according to DSM-IV-TR
2) Patients who fall under a contraindication listed in the ABILIFY package insert
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method